Ironwood Pharmaceuticals (IRWD) Invested Capital (2016 - 2026)

Ironwood Pharmaceuticals (IRWD) posted Invested Capital of $199.9 million for Q1 2026, little changed sequentially from $199.7 million in Q4 2025.

Ironwood Pharmaceuticals (IRWD) Invested Capital (2016 - 2026) Analysis & Trends

Ironwood Pharmaceuticals has reported Invested Capital for 9 years, with the latest figure at $199.9 million in Q1 2026.

Quarterly Invested Capital changed N/A year-over-year to $199.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $798.4 million (changed N/A YoY) and the FY2025 annual result came in at $199.7 million, changed N/A from the prior year.
Invested Capital was little changed at $199.9 million in Q1 2026 per IRWD's latest filing, from $199.7 million in the prior quarter.
Over five years, Invested Capital peaked at $199.9 million in Q1 2026 and troughed at $120.6 million in Q1 2022.
A 5-year average of $190.7 million and a median of $199.5 million in 2025 frame the typical range for Invested Capital.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	42.98 Bn	39.33 Bn	2.15 Bn	4.50 Bn
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	22.15 Bn	19.48 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.56 Bn	15.17 Bn	935.80 Mn	-
8	Elanco Animal Health	11.74 Bn	11.21 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	630.00 Mn
10	Ironwood Pharmaceuticals	668.31 Mn	589.18 Mn	-	-

Download Data